CLDN1 and irritable bowel syndrome: Studies have shown that Bifidobacterium and Lactobacillus can alleviate visceral hypersensitivity in IBS mice, inhibit inflammatory factors (IL-6 and IL-17), and promote the expression of tight junction proteins (claudin-1 and occludin) [108].